A recent analysis reveals that monthly prices of checkpoint inhibitors decreased only a small amount over a decade.

Checkpoint inhibitors are antibody-based cancer therapies that unlock the immune system’s natural ability to fight cancer. These treatments work by blocking special proteins called immune checkpoints, ...

3D rendering of a checkpoint inhibitor binding PD-1, a protein on the surface of an immune T cell. This article is part of an ongoing series on checkpoint inhibitors, a novel cancer immunotherapy.

Review explores how drug repurposing in oncology can reshape the tumor microenvironment, strengthen immune checkpoint ...

Review of current evidence indicates immune checkpoint inhibitors offer comparable efficacy and safety for NSCLC in people living with HIV, with no adverse impact on viral load or CD4 counts.

A new study led by researchers at the Johns Hopkins Kimmel Cancer Center found that patients with advanced basal cell ...

Absent tools such as rebate reform, transparent pricing or accelerated biosimilar substitution, true price competition will ...

Please provide your email address to receive an email when new articles are posted on . DESTIN, Fla. — Inflammatory arthritis as a result of immune checkpoint cancer therapy remains a pressing ...

Please provide your email address to receive an email when new articles are posted on . People with cancer who received statins during immune checkpoint inhibitor therapy had improved prognosis.

Some cancer treatments can affect the body’s endocrine system, prompting CU Anschutz physicians to establish an endocrine-oncology clinic that helps patients get specialized care quickly.

Despite the success of immune checkpoint inhibitors in revolutionizing oncology, their benefits remain limited to a small ...

ICIs are safe and effective for HIV-positive NSCLC patients, with no significant differences in survival outcomes compared to HIV-negative patients. The efficacy of immune checkpoint inhibitors was ...